CLVS
Allianz Asset Management’s Clovis Oncology, Inc. CLVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-31,436
| Closed | -$125K | – | 2344 |
|
|
2019
Q3 | $125K | Buy |
31,436
+9,098
| +41% | +$36.2K | ﹤0.01% | 2161 |
|
|
2019
Q2 | $332K | Sell |
22,338
-13,222
| -37% | -$197K | ﹤0.01% | 2032 |
|
|
2019
Q1 | $883K | Buy |
+35,560
| New | +$883K | ﹤0.01% | 1794 |
|
|
2018
Q4 | – | Sell |
-50,665
| Closed | -$1.49M | – | 2235 |
|
|
2018
Q3 | $1.49M | Sell |
50,665
-144,760
| -74% | -$4.25M | ﹤0.01% | 1656 |
|
|
2018
Q2 | $8.89M | Sell |
195,425
-5,203
| -3% | -$237K | 0.01% | 1016 |
|
|
2018
Q1 | $10.6M | Sell |
200,628
-39,663
| -17% | -$2.09M | 0.01% | 965 |
|
|
2017
Q4 | $16.3M | Sell |
240,291
-17,693
| -7% | -$1.2M | 0.01% | 784 |
|
|
2017
Q3 | $21.3M | Buy |
257,984
+115,991
| +82% | +$9.56M | 0.02% | 674 |
|
|
2017
Q2 | $13.2M | Buy |
141,993
+105,455
| +289% | +$9.78M | 0.01% | 878 |
|
|
2017
Q1 | $2.33M | Buy |
+36,538
| New | +$2.33M | ﹤0.01% | 1447 |
|
|
2016
Q2 | – | Sell |
-186,084
| Closed | -$3.57M | – | 2074 |
|
|
2016
Q1 | $3.57M | Buy |
186,084
+15,404
| +9% | +$296K | ﹤0.01% | 1240 |
|
|
2015
Q4 | $5.92M | Buy |
170,680
+7,370
| +5% | +$256K | 0.01% | 1074 |
|
|
2015
Q3 | $15M | Buy |
163,310
+64,095
| +65% | +$5.89M | 0.02% | 742 |
|
|
2015
Q2 | $8.72M | Sell |
99,215
-99,695
| -50% | -$8.76M | 0.01% | 967 |
|
|
2015
Q1 | $14.8M | Sell |
198,910
-315
| -0.2% | -$23.4K | 0.02% | 696 |
|
|
2014
Q4 | $11.2M | Buy |
199,225
+162,145
| +437% | +$9.08M | 0.01% | 766 |
|
|
2014
Q3 | $1.68M | Buy |
37,080
+1,175
| +3% | +$53.3K | ﹤0.01% | 1263 |
|
|
2014
Q2 | $1.49M | Buy |
+35,905
| New | +$1.49M | ﹤0.01% | 1279 |
|